These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
570 related articles for article (PubMed ID: 31300537)
41. A Bioinformatic Profile of Gene Expression of Colorectal Carcinoma Derived Organoids. A P; Xu X; Wang C; Ye L; Yang J Biomed Res Int; 2018; 2018():2594076. PubMed ID: 30363662 [TBL] [Abstract][Full Text] [Related]
42. Multiregion ultra-deep sequencing reveals early intermixing and variable levels of intratumoral heterogeneity in colorectal cancer. Suzuki Y; Ng SB; Chua C; Leow WQ; Chng J; Liu SY; Ramnarayanan K; Gan A; Ho DL; Ten R; Su Y; Lezhava A; Lai JH; Koh D; Lim KH; Tan P; Rozen SG; Tan IB Mol Oncol; 2017 Feb; 11(2):124-139. PubMed ID: 28145097 [TBL] [Abstract][Full Text] [Related]
43. Glioblastoma Model Using Human Cerebral Organoids. Ogawa J; Pao GM; Shokhirev MN; Verma IM Cell Rep; 2018 Apr; 23(4):1220-1229. PubMed ID: 29694897 [TBL] [Abstract][Full Text] [Related]
44. CRISPR/Cas9-Mediated Genome Editing of Mouse Small Intestinal Organoids. Schwank G; Clevers H Methods Mol Biol; 2016; 1422():3-11. PubMed ID: 27246017 [TBL] [Abstract][Full Text] [Related]
45. A Sleeping Beauty transposon-mediated screen identifies murine susceptibility genes for adenomatous polyposis coli (Apc)-dependent intestinal tumorigenesis. Starr TK; Scott PM; Marsh BM; Zhao L; Than BL; O'Sullivan MG; Sarver AL; Dupuy AJ; Largaespada DA; Cormier RT Proc Natl Acad Sci U S A; 2011 Apr; 108(14):5765-70. PubMed ID: 21436051 [TBL] [Abstract][Full Text] [Related]
46. Use of Organoids to Characterize Signaling Pathways in Cancer Initiation. Oatway C; Hirsch CL; Gregorieff A Methods Mol Biol; 2018; 1765():315-331. PubMed ID: 29589318 [TBL] [Abstract][Full Text] [Related]
47. Establishment and characterization of cell lines from chromosomal instable colorectal cancer. Maletzki C; Gock M; Randow M; Klar E; Huehns M; Prall F; Linnebacher M World J Gastroenterol; 2015 Jan; 21(1):164-76. PubMed ID: 25574089 [TBL] [Abstract][Full Text] [Related]
48. Colonoscopy-based colorectal cancer modeling in mice with CRISPR-Cas9 genome editing and organoid transplantation. Roper J; Tammela T; Akkad A; Almeqdadi M; Santos SB; Jacks T; Yilmaz ÖH Nat Protoc; 2018 Feb; 13(2):217-234. PubMed ID: 29300388 [TBL] [Abstract][Full Text] [Related]
49. The Axis of CXCR4/SDF-1 Plays a Role in Colon Cancer Cell Adhesion Through Regulation of the AKT and IGF1R Signalling Pathways. Zheng F; Zhang Z; Flamini V; Jiang WG; Cui Y Anticancer Res; 2017 Aug; 37(8):4361-4369. PubMed ID: 28739729 [TBL] [Abstract][Full Text] [Related]
50. Human Pancreatic Tumor Organoids Reveal Loss of Stem Cell Niche Factor Dependence during Disease Progression. Seino T; Kawasaki S; Shimokawa M; Tamagawa H; Toshimitsu K; Fujii M; Ohta Y; Matano M; Nanki K; Kawasaki K; Takahashi S; Sugimoto S; Iwasaki E; Takagi J; Itoi T; Kitago M; Kitagawa Y; Kanai T; Sato T Cell Stem Cell; 2018 Mar; 22(3):454-467.e6. PubMed ID: 29337182 [TBL] [Abstract][Full Text] [Related]
51. Single-cell genomic and transcriptomic landscapes of primary and metastatic colorectal cancer tumors. Wang R; Li J; Zhou X; Mao Y; Wang W; Gao S; Wang W; Gao Y; Chen K; Yu S; Wu X; Wen L; Ge H; Fu W; Tang F Genome Med; 2022 Aug; 14(1):93. PubMed ID: 35974387 [TBL] [Abstract][Full Text] [Related]
52. A small molecule approach to degrade RAS with EGFR repression is a potential therapy for KRAS mutation-driven colorectal cancer resistance to cetuximab. Lee SK; Cho YH; Cha PH; Yoon JS; Ro EJ; Jeong WJ; Park J; Kim H; Il Kim T; Min DS; Han G; Choi KY Exp Mol Med; 2018 Nov; 50(11):1-12. PubMed ID: 30459318 [TBL] [Abstract][Full Text] [Related]
53. Evaluation of Radiation Sensitivity Differences in Mouse Liver Tumor Organoids Using CRISPR/Cas9-Mediated Gene Mutation. Jeon W; Jung SY; Lee CY; Kim WT; Kim H; Jang KW; Lim H; Lee M; Jeong DH; Kim SD; Kim IA; Choi SH; Son TG; Kim KS Technol Cancer Res Treat; 2023; 22():15330338231165125. PubMed ID: 36960537 [TBL] [Abstract][Full Text] [Related]
54. Inactivation of interleukin-30 in colon cancer stem cells via CRISPR/Cas9 genome editing inhibits their oncogenicity and improves host survival. D'Antonio L; Fieni C; Ciummo SL; Vespa S; Lotti L; Sorrentino C; Di Carlo E J Immunother Cancer; 2023 Mar; 11(3):. PubMed ID: 36927528 [TBL] [Abstract][Full Text] [Related]
55. Mouse models for the discovery of colorectal cancer driver genes. Clark CR; Starr TK World J Gastroenterol; 2016 Jan; 22(2):815-22. PubMed ID: 26811627 [TBL] [Abstract][Full Text] [Related]
56. Gasdermin C Is Upregulated by Inactivation of Transforming Growth Factor β Receptor Type II in the Presence of Mutated Apc, Promoting Colorectal Cancer Proliferation. Miguchi M; Hinoi T; Shimomura M; Adachi T; Saito Y; Niitsu H; Kochi M; Sada H; Sotomaru Y; Ikenoue T; Shigeyasu K; Tanakaya K; Kitadai Y; Sentani K; Oue N; Yasui W; Ohdan H PLoS One; 2016; 11(11):e0166422. PubMed ID: 27835699 [TBL] [Abstract][Full Text] [Related]
57. TrkC promotes colorectal cancer growth and metastasis. Kim MS; Suh KW; Hong S; Jin W Oncotarget; 2017 Jun; 8(25):41319-41333. PubMed ID: 28455963 [TBL] [Abstract][Full Text] [Related]
58. SLC25A22 Promotes Proliferation and Survival of Colorectal Cancer Cells With KRAS Mutations and Xenograft Tumor Progression in Mice via Intracellular Synthesis of Aspartate. Wong CC; Qian Y; Li X; Xu J; Kang W; Tong JH; To KF; Jin Y; Li W; Chen H; Go MY; Wu JL; Cheng KW; Ng SS; Sung JJ; Cai Z; Yu J Gastroenterology; 2016 Nov; 151(5):945-960.e6. PubMed ID: 27451147 [TBL] [Abstract][Full Text] [Related]
59. Genome-Wide CRISPR/Cas9 Screening for Identification of Cancer Genes in Cell Lines. Adelmann CH; Wang T; Sabatini DM; Lander ES Methods Mol Biol; 2019; 1907():125-136. PubMed ID: 30542996 [TBL] [Abstract][Full Text] [Related]